#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Human papilloma virus immunisation Non-small cell lung cancer metastatic Glioblastoma Glomerulonephritis rapidly progressive Anti-glomerular basement membrane disease Acute promyelocytic leukaemia Mucopolysaccharidosis I Hyperinsulinaemic hypoglycaemia Mucous membrane pemphigoid Progressive supranuclear palsy Transplant rejection Vitamin B12 deficiency Diabetes insipidus Retinopathy of prematurity IgA nephropathy More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung – Life with Disease Carcinoid syndrome Bronchiolitis obliterans syndrome Thrombotic thrombocytopenic purpura – Treatment SAPHO syndrome Sarcoma – Treatment Pleomorphic leiomyosarcoma – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Toxic epidermal necrolysis – Life with Disease Cystic fibrosis lung – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sevoflurane Valbenazine Ditosylate A49 Doconexent Tozorakimab GSKVX000000030810 Thymalfasin METHYLPHENIDATE SPY002 Ambrisentan Iron EGANELISIB Levobupivacaine Hydrochloride Opevesostat Atuliflapon [11C]Az14193391 Sodium Sulfate Anhydrous Progesterone, Micronised Sotagliflozin Adezunap More therapies…

    Learn about Your Condition

    Breast cancer Pyoderma gangrenosum Neonatal asphyxia Tuberculosis Mixed-type liposarcoma Arteriovenous malformation Ichthyosis Cardiac disorder Alcohol abuse Neuroendocrine carcinoma Pouchitis Vulvar dysplasia Tendon rupture Organ donor Yellow fever More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Prostate cancer

  • Safety Study of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Patients with Metastatic Colorectal or Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Colorectal cancer metastatic
    • Prostate cancer
    Investigated Drugs:
    • Aldesleukin
    • Mesna
    • Cyclophosphamide Monohydrate
    Germany

  • Study on Darolutamide for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Darolutamide
    Sweden

  • Study on Sildenafil and Vacuum Erection Device Therapy for Men with Prostate Cancer Undergoing Nerve-Sparing Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • PAPAVERINE HYDROCHLORIDE
    • PHENTOLAMINE MESILATE
    • Sildenafil
    The Netherlands

  • Study of 99mTc-MIP-1404 SPECT/CT imaging compared to standard imaging methods for detecting lymph node metastases in patients with prostate cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 18F-Psma-1007
    • TROFOLASTAT
    • Piflufolastat (18F)
    Finland

  • Study on the Effect of Degarelix on Prostate-Specific Membrane Antigen in Patients with Untreated Metastatic Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Prostate cancer
    Investigated Drugs:
    • Degarelix
    Finland

  • Study of [177Lu]Lu-PSMA-I&T Therapy for Patients with Oligometastatic Prostate Cancer Using Gozetotide and Stannous Oxide Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 3,3-Diphosphono-1,2-Propanedicarboxylic Acid, Tetrasodium Salt (Dpd)
    • Lutetium (177Lu) Zadavotide Guraxetan
    • Gozetotide
    Austria
Previous Page
1 2 3 4 … 17
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!